Literature DB >> 17441838

Hyperechogenicity of the substantia nigra in Parkinson's disease.

Pavel Ressner1, David Skoloudík, Petr Hlustík, Petr Kanovský.   

Abstract

Substantia nigra (SN) was assessed by transcranial sonography (TCS) in 47 Parkinson's disease (PD) patients and in 39 healthy volunteers. A semiquantitative echogenicity scale was created with arbitrary values ranging from 1 to 5, zones with grade >or=3 and larger than 0.19 cm(2) were recorded as hyperechogenic SN. TCS examination of SN as a diagnostic test for PD in our study showed 87.2% sensitivity and 94.9% specificity.

Entities:  

Mesh：

Year:  2007        PMID： 17441838     DOI： 10.1111/j.1552-6569.2007.00114.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN： 1051-2284            Impact factor:   2.486


  12 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Transcranial sonography of the substantia nigra: digital image analysis.

Authors:  D Skoloudík; M Jelínková; J Blahuta; P Cermák; T Soukup; P Bártová; K Langová; R Herzig
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-24       Impact factor: 3.825

Review 3.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

4.  Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.

Authors:  Ivanka Štenc Bradvica; Ivan Mihaljević; Silva Butković-Soldo; Dragutin Kadojić; Marina Titlić; Mario Bradvica; Kristina Kralik
Journal:  Neurol Sci       Date:  2015-03-19       Impact factor: 3.307

Review 5.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

6.  The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).

Authors:  Patrizio Prati; A Bignamini; L Coppo; A Naldi; C Comi; R Cantello; G Gusmaroli; U Walter
Journal:  J Neural Transm (Vienna)       Date:  2017-04-27       Impact factor: 3.575

Review 7.  Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review.

Authors:  Annemarie M M Vlaar; Angela Bouwmans; Werner H Mess; Selma C Tromp; Wim E J Weber
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

8.  Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.

Authors:  Kristina Laučkaitė; Daiva Rastenytė; Danguolė Šurkienė; Antanas Vaitkus; Andrius Sakalauskas; Arūnas Lukoševičius; Rymantė Gleiznienė
Journal:  BMC Neurol       Date:  2012-03-08       Impact factor: 2.474

9.  Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients.

Authors:  Angela E P Bouwmans; Wim E J Weber; Albert F G Leentjens; Werner H Mess
Journal:  PeerJ       Date:  2016-05-18       Impact factor: 2.984

10.  Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.

Authors:  Angela E P Bouwmans; Annemarie M M Vlaar; Werner H Mess; Alfons Kessels; Wim E J Weber
Journal:  BMJ Open       Date:  2013-04-02       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.